Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
With Obesity on the Continued Rise in the U.S., More Anti-Obesity Drugs Are Heading for the Market
BioSpace
obesity
Sanofi
Novo Nordisk
AstraZeneca
Flag link:
Obalon Scores Funding on the Heels of Obesity Market Shift
Obalon Scores Funding on the Heels of Obesity Market Shift
Medical Devices and Diagnostics Industry
Obalon
obesity
devices
Flag link:
LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity
LNC Therapeutics Acquires Exclusive License for Microbes Potentially Related to Obesity
CP Wire
LNC Therapeutics
microbiome
obesity
Flag link:
Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs
Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs
Forbes
obesity
Belviq
Flag link:
Novo Nordisk adds to diabetes pipeline with Evotec deal
Novo Nordisk adds to diabetes pipeline with Evotec deal
Fierce Biotech
Novo Nordisk
Evotec
drug development
small molecule drugs
obesity
diabetes
Flag link:
Eisai obesity drug Belviq may have an edge with new heart safety data—but to what end?
Eisai obesity drug Belviq may have an edge with new heart safety data—but to what end?
Fierce Pharma
Eisai
obesity
Belviq
Flag link:
Omada Health launches new programs for obesity-related diseases
Omada Health launches new programs for obesity-related diseases
Healthcare Dive
Omada Health
digital therapeutics
hypertension
diabetes
obesity
Flag link:
Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs
Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs
Yahoo/Zacks.com
Novo Nordisk
R&D
Kallyope
diabetes
obesity
Flag link:
Building up its rare obesity pipeline, Rhythm Pharma to raise $150M
Building up its rare obesity pipeline, Rhythm Pharma to raise $150M
Endpoints
Rhythm Pharmaceuticals
R&D
obesity
Flag link:
Gut Microbes Associated With Obesity May Contribute to Depression and Anxiety
Gut Microbes Associated With Obesity May Contribute to Depression and Anxiety
CP Wire
microbiome
obesity
anxiety
depression
Flag link:
Novo Nordisk's semaglutide spurs major weight loss in phase 2 obesity study
Novo Nordisk's semaglutide spurs major weight loss in phase 2 obesity study
Fierce Pharma
Novo Nordisk
obesity
semaglutide
Flag link:
Building on impressive data, Novo Nordisk maps big PhIII obesity program for blockbuster hopeful semaglutide
Building on impressive data, Novo Nordisk maps big PhIII obesity program for blockbuster hopeful semaglutide
Endpoints
Novo Nordisk
obesity
semaglutide
Flag link:
Gelesis touts study of hydrogel obesity drug
Gelesis touts study of hydrogel obesity drug
Drug Delivery Business News
Gelesis
obesity
Gelesis100
Flag link:
Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall
Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall
Endpoints
Rhythm Pharmaceuticals
IPOs
obesity
rare disease
Flag link:
Novo focuses on new obesity therapy Semaglutide
Novo focuses on new obesity therapy Semaglutide
GoInPharma
Novo Nordisk
obesity
semaglutide
Flag link:
Can Novo’s blockbuster push on obesity drug semaglutide succeed where others failed?
Can Novo’s blockbuster push on obesity drug semaglutide succeed where others failed?
Endpoints
Novo Nordisk
semaglutide
obesity
Flag link:
Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial
Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial
Reuters
Novo Nordisk
obesity
semaglutide
Flag link:
J&J unveils new obesity, arthritis collaborations, shares its molecule library
J&J unveils new obesity, arthritis collaborations, shares its molecule library
Fierce Biotech
JNJ
obesity
rheumatoid arthritis
molecules
molecule library
drug development
Flag link:
Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1
Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1
Fierce Pharma
Novo Nordisk
Saxenda
Latin America
obesity
Flag link:
Zafgen starts comeback with first data on replacement weight loss drug
Zafgen starts comeback with first data on replacement weight loss drug
Fierce Biotech
Zafgen
obesity
beloranib
ZGN-1061
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »